 | Bobbe L. Ferraiolo, Marjorie A. Mohler, Carol A. Gloff - 1992 - 306 sivua
...37:85-88. Spriggs, DR, Sherman, ML, Michie, H., Arthur, K.. A., Imamura, K., Wilmore, D., Frei, E., Ill, and Kufe. DW, 1988, Recombinant human tumor necrosis...intravenous infusion. A phase I and pharmacologic study, J. Nail. Cancer fn.it. 80:1039-1044. Steinmetz, T., Schaadt. M., Gahl, R., Schenk. V., Diehl. V., and... | |
 | Pia Glas-Greenwalt - 1995 - 344 sivua
...malignancies. J Clin Oncol 1992; 10.1141-1152. 20. Spriggs DR. Sherman ML, Micbie H, et al. Recombinant human necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologie study. ] Nati Cancer Inst 1988; 80:1039-1044. 21. Michie HK. Spriggs DR. Manogue KR.... | |
 | Paula Trahan Rieger - 2001 - 844 sivua
...Cancer. Philadelphia, PA: JB Lippincott Co., pp. 354-377. Spriggs, D., Sherman, M., Michie, H., et al. 1988. Recombinant human tumor necrosis factor administered...study. Journal of the National Cancer Institute 80: 1039-1044. Steinmetz, T., Schaadt, M., Gahl, R., et al. 1988. Phase I study of 24-hour continuous intravenous... | |
 | F. E. G. Cox, L. H. Chappell - 2001 - 102 sivua
...Effect of S59 SPRIGGS, DR, SHERMAN, ML, MICHIE, H., ARTHUR, KA, IMAMURA, K., WILMORE, D., FREI, E. & KUFE, DW (1988). Recombinant human tumor necrosis...administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. Journal of the National Cancer Institute 80, 1039-1044. SWARTZBERG, JE,... | |
 | Carsten Nieder - 2003 - 308 sivua
...studies with tumour necrosis factor. Ciba Found Symp 131: 206-227 Spriggs DR, Sherman ML, Michie H et al (1988) Recombinant human tumor necrosis factor administered...intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst 80:1039-1044 Staba MJ, Mauceri HJ, Kufe DW et al (1998) Adenoviral TNFalpha gene... | |
 | Bela Bodey, Stuart E. Siegel, Hans E. Kaiser - 2004 - 396 sivua
...1988. 237. Spriggs DR, Sherman ML, Michie H, Arthur KA, 1mamura K, Wilmore D, Frei E 1ll, Kufe DW, Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. J Natl Cancer 1nst 80: 1 0391044, 1988. 238. Sherman ML, Spriggs DR, Arthur... | |
 | M. A. Kramer - 2005 - 190 sivua
...622. [188] Spriggs DR; Sherman ML, Michie H, Arthur KA, Imamura K, Wilmore D, Frei E 3rd, Kufe DW. Recombinant human tumor necrosis factor administered...intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst, 1988 80, 1039-1044. [189] Stachon A; Boning A, Weisser H, LaczKovics A, Skipka... | |
 | Aikakauslehti - Nide 73,Nro 5 - 104 sivua
...decrease of cholesterol during septic shock. Shock 1998;10:359-363. 6. Spriggs DR, Sherman ML, Michie H. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologie study. J Nati Cancer Inst 1988;80:1039-1044. 7. van Gameren MM, Willemse PH, Mulder NH,... | |
| |
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. 